ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease.

Ning Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.